Chronic α1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall: Modulation of responsiveness after vascular injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 9, 1996, Pages 1122-1129

  DeBlois, D ^a,d   Schwanz, S M ^a   Van Kleef, E M ^b   Su, J E ^a   Griffin, K A ^c   Bidani, A K ^c   Daemen, M J A P ^b   Lombardi, D M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

catecholamine; DNA replication; endothelium; vascular smooth muscle

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ASCORBIC ACID; BROXURIDINE; CATECHOLAMINE; DNA; NORADRENALIN; PHENYLEPHRINE;

ADRENERGIC SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 9544225050     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.9.1122     Document Type: Article

References (65)

1. Bevan RD. Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery. Circ Res. 1975;37: 14-19.
2. Bevan RD, Tsuru H. Functional and structural changes in the rabbit ear artery after sympathetic denervation. Circ Res. 1981;49:478-485.
3. Todd ME, Gowen B. Arterial wall and smooth muscle cell development in young Wistar rats and the effects of surgical denervation. Circ Res. 1991;69:438-446.
4. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens. 1986;4:515-524.
5. Adams MA, Bobik A, Korner PI. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Hypertension. 1989;14:191-202.
6. Lee RMKW, Smeda JS. Primary versus secondary structural changes of the blood vessels in hypertension. Can J Physiol Pharmacol. 1985;63:392-401.
7. Lee RMKW, Toggle CR, Cheung DT, Coughlin MD. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension. 1987;10: 328-338.
8. Head JH. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood. 1994;26:1-20.
9. Kukreja RS, Datta BN, Chakravarti RN. Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis. 1981;40:291-298.
10. Majesky MW, Reidy MA, Benditt EP, Juchau MR. Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc Natl Acad Sci U S A. 1985;82:3450-3454.
11. Bauch H-J, Grunwald J, Vischer P, Gerlach U, Hauss WH. A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosis. Exp Pathol. 1987;31:193-204.
12. Bylund DB. Subtypes of alpha-1- and alpha-2-adrenergic receptors. FASEB J. 1992;6:832-839.
13. Blaes N, Boissel JP. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol. 1983; 116:167-172.
14. Nakaki T, Nakayama M, Yamamoto S, Kato R. Alpha-1-adrenergic stimulation and beta-2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol. 1989;37:30-36.
15. Erlinge D, Yoo H, Edvinsson L, Reis DJ, Wahlestedt C. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol. 1993;265: H1089-H1097.
16. Fingerle J, Sanders KH, Fotev Z. Alpha-1 receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury. Basic Res Cardiol. 1991;86(suppl 1):75-81.
17. Jackson CL, Bush RC, Bowyer DE. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis. 1988;69:115-122.
18. O'Malley MK, McDermott EWM, Mehigan D, O'Higgins NJ. Role for prazosin in reducing the development of rabbit intimal hyperplasia after endothelial denudation. Br J Surg. 1989;76:936-938.
19. Vashisht R, Sian M, Franks PJ, O'Malley MK. Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin. Br J Surg. 1992;79:1285-1288.
20. Van Kleef EM, Smits JFM, DeMey JGR, Cleutjens JPM, Lombardi DM, Schwartz SM, Daemen MJAP. Alpha-1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res. 1992;70:1122-1127.
21. Majesky MW, Daemen MJAP, Schwartz SM. Alpha-1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J Biol Chem. 1990;265:1082-1088.
22. Bondjers G, Glukhova M, Hansson GK, Postnov YV, Reidy MA, Schwartz SM. Hypertension and atherosclerosis: cause and effect, or two effects with one unknown cause? Circulation. 1991;84(suppl VI):VI-2-VI-16.
23. Babaev VR, Bobryshev YV, Stenina OV, Tararak EM, Gabbiani G. Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol. 1990;136:1031-1042.
24. Printseva OJ, Peclo MM, Tjurmin AV, Faerman AI, Danilov SM, Repin VS, Smirnov VN. A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. Am J Pathol. 1989;134:305-313.
25. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheroscleromatous human arterial smooth muscle cells. Hum Pathol. 1986;17:875-880.
26. Majesky MW, Giachelli CM, Schwartz SM. Rat carotid neointimal smooth muscle cells re-express a developmentally regulated phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
27. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall. Circ Res. 1991;68:450-456.
28. Hedin U, Holm H, Hansson GK. Induction of tenascin in rat arterial injury: relationship to altered smooth muscle cell phenotype. Am J Pathol. 1991;139:649-656.
29. Giachelli CM, Bae N, Lombardi DM, Majesky MW, Schwartz SM. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991;177:867-873.
30. Reid IA. Interactions between Ang II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262:E763-E778.
31. Chiu AT, McCall DE, Thoolen MJMC, Timmermans PBMWN. Ca++ utilization in the constriction of rat aorta to full and partial alpha-1 adrenoreceptor agonists. J Pharmacol Exp Ther. 1986;238: 224-231.
32. Kriss JP, Révész L. The distribution and fate of bromodeoxyuridine and bromodeoxycitidine in the mouse and rat. Cancer Res. 1962;22:254-265.
33. Bidani AK, Griffin KA, Picken M, Lansky DM. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol. 1993;265:F391-F398.
34. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
35. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
36. Kleinjans J, Kasbergen C, Vervoort-Peters L, Smits J, Struyker Boudier HAJ. Chronic intravenous infusion of noradrenaline produces labile hypertension in conscious rats. Life Sci. 1981;29:509-514.
37. Van Kleef EM, Smits JFM, Schwartz SM, Daemen MJAP. Doxazosin blocks the angiotensin II-induced smooth muscle cell DNA synthesis in the media, but not the neointima of the rat carotid artery after balloon injury. Cariovasc Res. In press.
38. Sadoshima S, Fujii K, Yao H, Ibayashi S, Fujishima M. Effect of chronic sympathetic denervation on cerebrovascular hypertrophy during the development of hypertension in rats. Brain Res. 1986;379:205-209.
39. Majesky MW, Hsueh-Ying L, Juchau MR. Interaction of alpha and beta adrenergic stimulation on aortic ornithine decarboxylase activity. Life Sci. 1985;36:153-159.
40. Mulvany MJ, Baandrup U, Gundersen HLG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res. 1985;57:794-800.
41. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 1984;134:127-136.
42. Yamori Y, Mano M, Nara Y, Horie R, Catecholamine-induced polyploidization in vascular smooth muscle cells. Circulation. 1987;75(suppl I):I-92-I-95.
43. Printseva OY, Tjurmin AV. Proliferative response of smooth muscle cells in hypertension. Am J Hypertens. 1992;5(6 pt 2):118S-123S.
44. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
45. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
46. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
47. Geng YL, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 1995;147:251-266.
48. Candipan RC, Hsiun PTC, Pratt R, Cooke JP. Vascular injury augments adrenergic neurotransmission. Circulation. 1994;89:777-784.
49. Perez DM, Piascik MT, Graham RM. Solution-phase library screening for the identification of rare clones: isolation of an alpha-1D-adrenergic receptor cDNA. Mol Pharmacol. 1991;40:876-883.
50. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb. 1994;14:982-989.
51. Majesky MW, Reidy MA, Bowen-Pope DF, Wilcox JN, Schwartz SM. Platelet-derived growth factor (PDGF) ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
52. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol. 1984; 17:875-880.
53. Kocher O, Gabbiani G. Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture. Differentiation. 1986;32:245-251.
54. Walker L, Bowen-Pope DF, Ross R, Reidy MA. Production of PDGF-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986;83:7311-7315.
55. Joly GA, Schini VB, VanHoutte PM. Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992;71:331-338.
56. Douglas SA, Vickery-Clarck LM, Ohlstein EH. Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction. Eur J Pharmacol. 1994;255:81-89.
57. Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
58. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertens. 1984;2:581-587.
59. Story DF, Ziogas J. Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol Sci. 1987;8:269-271.
60. Purdy RE, Weber MA. Angiotensin II amplification of alpha-adrenergic vasoconstriction: role of receptor reserve. Circ Res. 1988;63:748-757.
61. 1 receptor expression. Arterioscler Thromb Vasc Biol. 1996;16:1130-1137.
62. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-813.
63. Luscher TF. The endothelium in hypertension: bystander, target or mediator? J Hypertens. 1994;12:S105-S116.
64. Widmann MD, Letsou GV, Phan S, Baldwin JC, Sumpio BE. Isolation and characterization of rabbit cardiac endothelial cells: response to cyclic strain and growth factors in vitro. J Surg Res. 1992;53:331-334.
65. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.